IL-21R Antibody (155516) [Dylight 488]
Novus Biologicals, part of Bio-Techne | Catalog # FAB5961K
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Monoclonal Rat IgG1 Clone # 155516
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant mouse IL-21 R
Cys20-Pro236
Accession # Q9JHX3
Cys20-Pro236
Accession # Q9JHX3
Specificity
Detects mouse IL-21 R in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human IL-21 R or recombinant mouse IL-2 R beta is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG1
Applications for IL-21R Antibody (155516) [Dylight 488]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-21R
Long Name
Interleukin 21 Receptor
Alternate Names
CD360, IL-21 R, IL21R, NILR
Gene Symbol
IL21R
Additional IL-21R Products
Product Documents for IL-21R Antibody (155516) [Dylight 488]
Product Specific Notices for IL-21R Antibody (155516) [Dylight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...